High expression of CD11c indicates favorable prognosis in patients with gastric cancer

doi:10.3748/wjg.v21.i31.9403

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 31

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7327)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

413

WORD

246

HTML

3377

Figures (1-2)

183

Tables (1-5)

190

Sum=4409

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

949

Download

1969

Sum=2918

Aug 21, 2015 (publication date) through Jun 28, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Aug 21, 2015; 21(31): 9403-9412
Published online Aug 21, 2015. doi: 10.3748/wjg.v21.i31.9403

Table 3 Three- and 5-year overall survival and disease-free survival probability and median survival time (mo) in the low and high CD11c expression groups

Expression level of CD11c	3-yr OS (95%CI)	5-yr OS (95%CI)	Median survival time (95%CI)¹	3-yr DFS (95%CI)	5-yr DFS (95%CI)	Median disease free time (95%CI)²
Low	39.2 (30.0-48.4)	29.0 (20.2-37.8)	28.0 (15.1-40.9)	24.0 (19.8-28.2)	11.9 (8.7-15.1)	18.0 (14.6-21.4)
High	67.7 (59.3-76.1)	51.4 (42.4-60.4)	67.0 (53.9-80.1)	63.7 (54.9-72.5)	49.1 (39.8-58.4)	64.0 (42.0-86.0)

¹Survival curve comparison, χ² = 6.801, P = 0.009;

²Disease-free curve comparison, χ² = 15.387, P < 0.001. OS: Overall survival; DFS: Disease-free survival.

Citation: Wang Y, Xu B, Hu WW, Chen LJ, Wu CP, Lu BF, Shen YP, Jiang JT. High expression of CD11c indicates favorable prognosis in patients with gastric cancer. World J Gastroenterol 2015; 21(31): 9403-9412
URL: https://www.wjgnet.com/1007-9327/full/v21/i31/9403.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i31.9403